artenimol has been researched along with docetaxel anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Ding, X; Jia, X; Jiang, J; Li, Y; Sharma, A; Wang, G; Xie, G | 1 |
| Cai, D; Chen, F; Diao, L; Hu, Y; Jin, H; Shen, A; Tao, J; Wang, S | 1 |
2 other study(ies) available for artenimol and docetaxel anhydrous
| Article | Year |
|---|---|
Application of sequential factorial design and orthogonal array composite design (OACD) to study combination of 5 prostate cancer drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cisplatin; Docetaxel; Doxorubicin; Drug Interactions; Humans; Male; Models, Statistical; Paclitaxel; Prostatic Neoplasms; Regression Analysis; Taxoids | 2017 |
pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2021 |